1. Boehme, Stefen A, Franz-Bacon, Karin, DiTirro, Danielle N, Ly, Tai Wei, Bacon, Kevin B. 2016. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis. In PloS one, 11, e0154874. doi:10.1371/journal.pone.0154874. https://pubmed.ncbi.nlm.nih.gov/27144281/
2. Skorodumova, L O, Belodedova, A V, Sharova, E I, Malyugin, B E. . [Search for genetic markers for precise diagnostics of keratoconus]. In Biomeditsinskaia khimiia, 65, 9-20. doi:10.18097/PBMC20196501009. https://pubmed.ncbi.nlm.nih.gov/30816092/
3. Jones, Isabelle C, Espindola, Milena S, Narayanan, Rohan, Bacon, Kevin B, Hogaboam, Cory M. 2019. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis. In Scientific reports, 9, 19796. doi:10.1038/s41598-019-56393-z. https://pubmed.ncbi.nlm.nih.gov/31875033/
4. Boehme, Stefen A, Franz-Bacon, Karin, Ludka, John, Ly, Tai Wei, Bacon, Kevin B. 2016. MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction. In PloS one, 11, e0167169. doi:10.1371/journal.pone.0167169. https://pubmed.ncbi.nlm.nih.gov/27935962/
5. Huang, Xing, Lu, Zhichao, He, Min, Chen, Chen, Sun, Yidan. 2022. A Prognostic Risk Model of a Novel Oxidative Stress-Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma. In Oxidative medicine and cellular longevity, 2022, 2262014. doi:10.1155/2022/2262014. https://pubmed.ncbi.nlm.nih.gov/36439693/
6. Tambi, Richa, Zehra, Binte, Nandkishore, Sharon, Uddin, Mohammed, Berdiev, Bakhrom K. 2023. Single-cell reconstruction and mutation enrichment analysis identifies dysregulated cardiomyocyte and endothelial cells in congenital heart disease. In Physiological genomics, 55, 634-646. doi:10.1152/physiolgenomics.00070.2023. https://pubmed.ncbi.nlm.nih.gov/37811720/
智鼠故事 
